References
- Cryns, V. and Yuan, J. (1998) "Proteases to die for", Genes Dev. 12, 1551–1570.
- Van der Heiden, M.G. and Thompson, C.B. (1999) "Bc1-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?", Nat. Cell. Biol. I, 209–216.
- Reed, J.C. (2001) "The Survivin saga goes in vivo", J. Clin. Investig. 108, 965–969.
- Altieri, D.C., Marchisio, P.C. and Marchisio, C. (1999) "Survivin apoptosis: an interloper between cell death and cell proliferation in cancer", Lab. Investig. 79, 1327–1333.
- Huang, D.C. and Strasser, A. (2000) "BH3-only proteins-essential initiators of apoptotic cell death", Cell 103, 839–842.
- Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X. (1998) "Bid, a Bc12 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors", Cell 94, 481–490.
- Gross, A., Yin, X.M., Wang, K., Wei, M.C., Jockel, J., Milliman, C., Erdjument-Bromage, H., Tempst, P. and Korsmeyer, S.J. (1999) "Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1 /Fas death", J. Biol. Chem. 274, 1156–1163.
- Li, H., Zhu, H., Xu, C.J. and Yuan, J. (1998) "Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis", Cell 94, 491–501.
- Barna, G., Sebestyen, A., Chinopoulos, C.C., Nagy, K., Mihalik, R., Paku, S. and Kopper, L. (2002) "TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8", Anticancer Res. 22, 3867–3872.
- Slee, E.A., Keogh, S.A. and Martin, S.J. (2000) "Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bd-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cyto-chrome c release", Cell Death Differ. 7, 556–565.
- Wesselborg, S., Engels, I.H., Rossmarm, E., Los, M. and Schulze-Osthoff, K. (1999) "Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ ligand interaction", Blood 93,3053–3063.
- Ferrari, D., Stepczynska, A., Los, M., Wesselborg, S. and Schulze-Osthoff, K. (1998) "Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis", J. Exp. Med. 188, 979–984.
- Boehrer, S., Chow, K.U., Beske, F., Kukoc-Zivojnov, N., Puccetti, E., Ruthardt, M., Baum, C., Rangnekar, V.M., Hoelzer, D., Mitrou, P.S. and Weidmann, E. (2002) "In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl- 2 and promoting disruption of mitochondrial membrane potential and caspase activation", Cancer Res. 62, 1768–1775.
- Qiu, S.G., Krishnan, S., Guendy, N. and Rangnekar, V.M. (1999) "Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation", Oncogene 18, 7115–7123.
- de Thonel, A., Bettaieb, A., Jean, C., Laurent, G. and Quillet-Mary, A. (2001) "Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukemic cells", Blood 98, 3770–3777.
- Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, ES. and Wang, X. (1997) "Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade", Cell 91, 479–489.
- Lauber, K., Appel, H.A., Schlosser, S.F., Gregor, M., Schulze-Osthoff, K. and Wesselborg, S. (2001) "The adapter protein apoptotic protease-activating factor-1 (Apaf-1) is proteolyti-cally processed during apoptosis", J. Biol. Chem. 276, 29772–29781.
- Altieri, D.C. (2003) "Validating survivin as a cancer therapeutic target", Nat. Rev. Cancer 3, 46–54.
- Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsa-kopoulou, V, Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B. and Korsmeyer, S.J. (2001) "Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death", Science 292, 727–730.